# Melatonin in Smoke-induced Vascular Injury

> **NCT02591238** · PHASE4 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 68 (actual)

## Conditions studied

- Smoking
- Vascular System Injuries

## Interventions

- **OTHER:** non-smoker oral placebo
- **DRUG:** non-smoker oral melatonin
- **OTHER:** smoker oral placebo
- **DRUG:** smoker oral melatonin

## Key facts

- **NCT ID:** NCT02591238
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-10
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2016-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02591238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02591238, "Melatonin in Smoke-induced Vascular Injury". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02591238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
